Acute lymphoblastic leukaemia trials in United States
232 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleLocal Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
- Where
- Pittsburgh
- Age
- 18 years to 79 years
- People
- 30
- Run by
- John Lister
See details and how to joinNCT05281809 - No phaseTaking peopleFeasibility/Acceptability of Attentional-Control Training in Survivors
- Where
- Washington D.C.
- Age
- 8 years to 16 years
- People
- 50
- Run by
- Children's National Research Institute
See details and how to joinNCT05528939 - No phaseTaking peopleVirtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia
- Where
- Washington D.C.
- Age
- 7 years and over
- People
- 40
- Run by
- Children's National Research Institute
See details and how to joinNCT06722638 - Phase 1Taking peopleTagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Where
- Ann Arbor, Atlanta, Baltimore, Bethesda, Boston, Charlotte, Chicago, Cincinnati, Cleveland, Columbus, Dallas, Denver, Fort Worth, Houston, Indianapolis, Los Angeles, Memphis, Miami, Milwaukee, Minneapolis, New York, Orange, Philadelphia, Portland, Salt Lake City, San Francisco, Seattle, Washington D.C.
- Age
- 1 year to 21 years
- People
- 54 worldwide
- Run by
- Therapeutic Advances in Childhood Leukemia Consortium
See details and how to joinNCT05476770 - No phaseEnrolling by invitationA Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007
- Where
- Duarte, Los Angeles, Philadelphia, St Louis
- Age
- 12 years and over
- People
- 44 worldwide
- Run by
- Allotera Therapeutics
See details and how to joinNCT05509855 - Phase 1Taking peopleStudy of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
- Where
- Birmingham, Cincinnati, Houston, Nashville, Seattle
- Age
- 18 years and over
- People
- 36
- Run by
- Vincerx Pharma, Inc.
See details and how to joinNCT06034275 - Phase 2Taking peopleBlinatumomab After TCR Alpha Beta/CD19 Depleted HCT
- Where
- Milwaukee
- Age
- Up to 25 years
- People
- 25
- Run by
- Medical College of Wisconsin
See details and how to joinNCT04746209